[HTML][HTML] Targeting the tumor microenvironment: Potential strategy for cancer therapeutics

Q Babar, A Saeed, TA Tabish, M Sarwar… - Biochimica et Biophysica …, 2023 - Elsevier
Cellular and stromal components including tumor cells, immune cells, mesenchymal cells,
cancer-linked fibroblasts, and extracellular matrix, constituent tumor microenvironment …

Copper depletion as a therapeutic strategy in cancer

J Lopez, D Ramchandani, L Vahdat - Met. Ions Life Sci, 2019 - degruyter.com
Copper is an essential trace element that plays a critical role in a variety of basic biological
functions, and serves as a key component in a number of copper-dependent enzymes that …

Engineering a photosensitizer nanoplatform for amplified photodynamic immunotherapy via tumor microenvironment modulation

Y Zhou, X Ren, Z Hou, N Wang, Y Jiang, Y Luan - Nanoscale horizons, 2021 - pubs.rsc.org
Photosensitizer-based photodynamic therapy (PDT) can not only kill tumor cells by the
generated cytotoxic reactive oxygen species (ROS), but also trigger immunogenic cell death …

Dual-Targeting Biomimetic Nanomaterials for Photo-/Chemo-/Antiangiogenic Synergistic Therapy

Y Zhang, N Yang, Z Dong, J Wu, R Liao… - … Applied Materials & …, 2023 - ACS Publications
Avoiding the low specificity of phototheranostic reagents at the tumor site is a major
challenge in cancer phototherapy. Meanwhile, angiogenesis in the tumor is not only the …

Roles of copper-binding proteins in breast cancer

S Blockhuys, P Wittung-Stafshede - International journal of molecular …, 2017 - mdpi.com
Copper ions are needed in several steps of cancer progression. However, the underlying
mechanisms, and involved copper-binding proteins, are mainly elusive. Since most copper …

Modulating secreted components of tumor microenvironment: A masterstroke in tumor therapeutics

H Patel, P Nilendu, D Jahagirdar, JK Pal… - Cancer Biology & …, 2018 - Taylor & Francis
The microenvironment in which cancer resides plays an important role in regulating cancer
survival, progression, malignancy and drug resistance. Tumor microenvironment (TME) …

SPARC in cancer‐associated fibroblasts is an independent poor prognostic factor in non‐metastatic triple‐negative breast cancer and exhibits pro‐tumor activity

LB Alcaraz, A Mallavialle, C Mollevi… - … Journal of Cancer, 2023 - Wiley Online Library
Triple‐negative breast cancer (TNBC) is the most aggressive breast cancer subtype and
lacks specific targeted therapeutic agents. The current mechanistic evidence from cell …

Oligo-metastatic cancers: putative biomarkers, emerging challenges and new perspectives

A Ottaiano, M Santorsola, L Circelli, AM Trotta, F Izzo… - Cancers, 2023 - mdpi.com
Simple Summary Oligometastatic disease is a condition in oncology where cancer affects
only a few distant sites. It is associated with a low-burden spread and a more favorable …

[HTML][HTML] A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironment

LB Alcaraz, A Mallavialle, T David, D Derocq… - Theranostics, 2021 - ncbi.nlm.nih.gov
Rationale: Alternative therapeutic strategies based on tumor-specific molecular targets are
urgently needed for triple-negative breast cancer (TNBC). The protease cathepsin D (cath …

Relationships between biological heavy metals and breast cancer: a systematic review and meta-analysis

L Liu, J Chen, C Liu, Y Luo, J Chen, Y Fu, Y Xu… - Frontiers in …, 2022 - frontiersin.org
Introduction Heavy metals were classified as essential, probably essential, and potentially
toxic in the general population. Until now, it has been reported inconsistently on the …